Francois Ghiringhelli Selected Research

Francois Ghiringhelli Research Topics

Disease

41	Neoplasms (Cancer) 04/2024 - 12/2006
24	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 09/2009
9	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2010
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 01/2017
5	Adenocarcinoma 04/2023 - 07/2014
4	Disease Progression 08/2020 - 01/2017
3	Anus Neoplasms (Anal Cancer) 04/2024 - 01/2022
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 02/2013
3	Prostatic Neoplasms (Prostate Cancer) 08/2020 - 02/2013
2	Infections 04/2024 - 01/2022
2	Ependymoma 08/2022 - 11/2012
2	Carcinoma (Carcinomatosis) 01/2022 - 08/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 08/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 05/2018
2	Breast Neoplasms (Breast Cancer) 08/2020 - 12/2016
2	Splenomegaly 05/2020 - 05/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 10/2016
2	Lung Neoplasms (Lung Cancer) 01/2019 - 11/2018
1	Colitis 04/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024
1	Acute Kidney Injury (Acute Renal Failure) 04/2024
1	Sarcoidosis (Schaumann Disease) 04/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Hand-Foot Syndrome 01/2023
1	Intestinal Perforation 01/2023
1	Asthenia 01/2023
1	Rectal Neoplasms (Rectal Cancer) 08/2021
1	Sarcoma (Soft Tissue Sarcoma) 05/2021
1	COVID-19 11/2020
1	Hypoalbuminemia 11/2020
1	Lymphopenia (Lymphocytopenia) 11/2020
1	Endometrial Neoplasms (Endometrial Cancer) 08/2020
1	Ovarian Neoplasms (Ovarian Cancer) 08/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Mucositis 12/2019

Drug/Important Bio-Agent (IBA)

14	Bevacizumab (Avastin)FDA Link 08/2022 - 09/2009
9	Fluorouracil (Carac)FDA LinkGeneric 04/2024 - 09/2009
9	Irinotecan (Camptosar)FDA LinkGeneric 08/2021 - 09/2009
8	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2016
7	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2020
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2021 - 07/2010
5	atezolizumabIBA 04/2024 - 10/2020
5	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 11/2012
5	LigandsIBA 04/2024 - 12/2006
5	folfirinoxIBA 01/2022 - 05/2018
4	Leucovorin (Folinic Acid)FDA Link 08/2021 - 02/2015
3	Programmed Cell Death 1 ReceptorIBA 04/2024 - 01/2020
3	tremelimumabIBA 04/2023 - 01/2018
3	durvalumabIBA 04/2023 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2016
2	HMPL-013IBA 04/2024 - 01/2023
2	Docetaxel (Taxotere)FDA Link 04/2024 - 01/2022
2	NivolumabIBA 04/2024 - 01/2017
2	Monoclonal AntibodiesIBA 11/2023 - 10/2020
2	RNA (Ribonucleic Acid)IBA 10/2023 - 04/2023
2	Gemcitabine FDA Link 04/2023 - 02/2015
2	regorafenibIBA 01/2023 - 05/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2022 - 11/2012
2	Cancer VaccinesIBA 01/2022 - 01/2022
2	AntibodiesIBA 01/2022 - 08/2009
2	AntigensIBA 11/2021 - 10/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021 - 09/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2020 - 12/2016
2	olaparibIBA 08/2020 - 12/2016
2	EnzymesIBA 12/2019 - 12/2016
2	raltitrexed (D 1694)IBA 09/2019 - 07/2010
2	Lomustine (CCNU)FDA Link 01/2019 - 10/2016
2	Angiogenesis InhibitorsIBA 05/2014 - 02/2013
1	pembrolizumabIBA 04/2024
1	avelumabIBA 04/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2023
1	Pyruvate KinaseIBA 10/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023
1	trifluridine tipiracil drug combinationIBA 01/2023
1	SuspensionsIBA 10/2022
1	VaccinesIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021
1	NucleotidesIBA 11/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Panitumumab (Vectibix)FDA Link 01/2021
1	C-Reactive ProteinIBA 11/2020
1	ProcalcitoninIBA 11/2020
1	Everolimus FDA Link 12/2019

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 04/2024 - 07/2010
24	Therapeutics 01/2023 - 08/2009
10	Immunotherapy 11/2023 - 12/2006
4	Radiotherapy 11/2023 - 10/2008
4	Precision Medicine 08/2020 - 12/2016
2	Chemoradiotherapy 01/2022 - 10/2016
2	Neoadjuvant Therapy 08/2019 - 11/2018
2	Induction Chemotherapy 01/2018 - 04/2015